Рефрактерная стенокардия: что мы можем предложить пациенту?
Аннотация
Рефрактерная стенокардия – сравнительно редкое состояние, которое, тем не менее, является актуальной проблемой современной кардиологии. В статье приведены определения этого заболевания, даны алгоритмы диагностики и терапии. Особое внимание уделено вопросам модулирования метаболизма в миокарде как патогенетического способа фармакотерапии рефрактерной стенокардии.
Об авторах
С. Н. ТерещенкоРоссия
И. В. Жиров
Россия
Список литературы
1. Chester MR. Chronic refractory angina. Br J Cardiol 2000; 7: 108-11.
2. Лупанов В.П. Диагностика и лечение рефрактерной стенокардии. РМЖ 2004; 12: 104-7.
3. Mannheimer C, Camici P, Chester M, et al. The problem of chronic refractory angina; report from the ESC Joint Study Group on the Treatment of Refractory Angina.Eur Heart J 2002; 23: 355-70.
4. Whitlow P, Dimas A, Bashore T, et al. Relationship of extent of revascularization with angina at one year in the Bypass Angioplasty Revascularization Investigation (BARI). JACC 1999; 34: 1750-9.
5. CABRI Trial Participants. First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation). Lancet 1995; 346: 1179-84.
6. Moore R, Groves D, Nolan J, et al. Altered short term heart rate variability with spinal cord stimulation in chronic refractory angina: evidence for the presence of procedure related cardiac sympathetic blockade. Heart 2004; 90: 211-2.
7. Randle P, Garland P, Hales C, et al. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; 1: 785-9.
8. Crozatier B, Badoual T, Boehm E, et al. Role of creatine kinase in cardiac excitation-contraction coupling: studies in creatine kinase-deficient mice. FASEB J 2002; 16: 653-60.
9. Weiss RG, Chatham G, Georgakopoulos D, et al. An increase in the myocardial PCr/ATP ratio in GLUT4 null mice. FASEB J 2002; 16: 613-5.
10. Ingwall JS. Transgenesis and cardiac energetics: new insights into cardiac metabolism. J Mol Cell Cardiol 2004; 37: 613-23.
11. Belke DD, Betuing S, Tuttle G, et al. Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest 2002; 109: 629-39.
12. Watanabe K, Fujii H, Katakashi T, et al. Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor alpha associated with age-dependent cardiac toxicity. J Biol Chem 2000; 275: 2293-9.
13. Kantor P, Lucien A, Kozak P, et al. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Cir Res 2000; 86: 580-8.
14. Vladimir I. Influencing myocardial energy metabolism as a therapeutic principle. Clin Drug Invest 2004; 24: 731-8.
15. Detry J, Sellier P, Pennaforte S, et al. Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group. Br J Clin Pharmacol 1994; 37: 279-88.
16. Kolbel F, Bada V. Trimetazidine in geriatric patients with stable angina pectoris: the TIGER study. Int J Clin Pract 2003; 57: 867- 70.
17. Chaitman B, Scettino S, Parker J, et al. Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. JACC 2004; 43: 1375-82.
18. Opie LH. The Heart. 3rd Ed. Philadelphia, Pa: Lippincott-Raven 1998.
19. Kates A, Herrero P, Dence C, et al. Impact of aging on substrate metabolism by the human heart. JAСC 2003; 41: 293-9.
20. Davila-Roman V, Vidala G, Herrero P, et al. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. JACC 2002; 40: 271-7.
21. Fisher DJ. Oxygenation and metabolism in the developing heart. Semin Perinatol 1984; 8: 217-25.
22. Razeghi P, Young M, Alcorn J, et al. Metabolic gene expression in fetal and failing human heart. Circulation 2001; 104: 2923-31.
Рецензия
Для цитирования:
Терещенко С.Н., Жиров И.В. Рефрактерная стенокардия: что мы можем предложить пациенту? Кардиоваскулярная терапия и профилактика. 2007;6(4):103-106.
For citation:
Tereshchenko S.N., Zhirov I.V. Refractory angina: what to offer to our patients? Cardiovascular Therapy and Prevention. 2007;6(4):103-106. (In Russ.)